28 May 2026

eviQ Education redesigning MABs and ICIs eLearning

eviQ Education is redesigning its Monoclonal Antibodies (MABs) and Immune Checkpoint Inhibitors (ICIs) eLearning, and cancer nurses are encouraged to provide input through a short Learning Needs Analysis survey.

MABs and ICIs continue to evolve rapidly, with new therapies, indications and approaches to toxicity management emerging across cancer care. As these treatments become increasingly embedded in practice, it is essential that education remains current, practical and relevant to the needs of clinicians at the point of care.

The redesign will focus on ensuring the eLearning reflects contemporary practice and supports clinicians with clear, accessible and useful information.

Your feedback will help shape:

what content stays, what is removed and what can be simplified
how the learning is delivered, including whether content is best presented through comprehensive modules or shorter rapid-learning options
what additional information should be included to better support clinical practice.

This is a valuable opportunity for CNSA members to contribute their frontline experience and help ensure future MABs and ICIs education meets the needs of cancer nurses and other clinicians delivering care.

Members are encouraged to complete the Learning Needs Analysis survey and share their perspectives.

Survey closes: 30 June 2026